Create knowledge
[?]
|
(rate this)
|
|
Yes
|
7
|
VS |
3
|
No
|
 |
Sunil S Chiplunkar
| Argues in support of
"No"
| 2 years ago
|
|
Fantastic debate question - however, we are obfuscating two seperate issues. Breaking or bypassing patents is a legal and legitimate business opportunity. One has to address this with all wherewithals. Take for instance, the patent gambit taken...
|
|
 |
Pratibha Rana
| Argues in support of
| 3 years ago
|
|
I know the bottom line is revenue but most of the co. revenue is spent on fighting on patents. The latest fight was between two co. for cancer drug and its patent.
|
|
 |
Steven
| Argues in support of
"Yes"
| 3 years ago
|
|
i think R D is significant for development of pharmaceucal companies which are research-based. furthermore, many drugs's patent will be overdue, MPCs need substitutes and supplyments to sustain theri markets and achieve revenues. Â
|
|
Debate: "Pharma's Expenditure on R&D or Patents" deleted from your view.
|
(rate this)
|
Answer: "How do you ensure compliance, cost effectively, in Development in the pharmaceutical industry?" deleted from your view.
|
(rate this)
|
Answer: "The price tag for a new drug from development to approval is close to 1 Billion Dollars. Is the FDA properly protecting us..." deleted from your view.
|
(rate this)
|
Can you get fined? Are you liable for withholding information inadvertently?
 |
Ajoy Mondal
| Answered
| 4 years ago
|
|
FDA does not respond favorably to incomplete submissions. In the case of submissions for approvals, the agency simply rejects them. It is not likely that there would be a fine. Some consequences may occur if the submission is required...
|
|
Answer: "How does the FDA respond if your applications are incomplete?" deleted from your view.
|
(rate this)
|
The first wave of IT improvements solved some problems, but opportunities remain. Now it's time for a more comprehensive approach. One of the largest barriers pharmaceutical companies face in bringing new drugs to market is the clinical trial process. Often paper-based and always subject to intense regulatory pressure, clinical trials involve managing massive amounts of documentation between multiple parties and systems. A clinical trial solution based on the Microsoft Office System can help make it easier to plan effective trials, capture patient data, and manage administration tasks more efficiently. Today, pharmaceutical companies struggle with the following challenges: Lengthy and compl...
Insight: "Clinical Trials Through the use of IT" deleted from your view.
|
(rate this)
|
|
|
Ajoy Mondal
| Answered
| 4 years ago
|
|
The clinical investigation of a previously untested drug is generally divided into three phases. Although in general the phases are conducted sequentially, they may overlap. The three phases of an investigation are as follows: Phase 1; includes...
|
|
 |
Bindu Narayan
| Answered
| 3 years ago
|
|
Thousands of chemicals, both synthetic and extracted from "natural" sources, are being examined in the hope of finding new drugs with which to combat human and veterinary diseases. The first step is to use laboratory tests to find if these...
|
|
Answer: "What are the steps that needs to be fllowed for testing a new drug?" deleted from your view.
Follow me on
